SERUM PSEUDOCHOLINESTERASE LEVEL AS A PROGNOSTIC BIOMARKER IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Espinoza, Karina Sato
Chotiprasidhi, Perapa
Roberts, Lewis R.
Wangensteen, Kirk J.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1167
引用
收藏
页码：S681 / S681
页数：1
相关论文
共 50 条
  • [1] Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma
    Bo Zhang
    Cheng Shen
    Jie Jin
    Yi Song
    Zheng Zhao
    Xiaochun Zhang
    Gang Wang
    Yu Fan
    Yue Mi
    Shuai Hu
    Yun Cui
    Liqun Zhou
    Zhisong He
    Wei Yu
    Wenke Han
    International Urology and Nephrology, 2016, 48 : 1993 - 1999
  • [2] Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma
    Zhang, Bo
    Shen, Cheng
    Jin, Jie
    Song, Yi
    Zhao, Zheng
    Zhang, Xiaochun
    Wang, Gang
    Fan, Yu
    Mi, Yue
    Hu, Shuai
    Cui, Yun
    Zhou, Liqun
    He, Zhisong
    Yu, Wei
    Han, Wenke
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (12) : 1993 - 1999
  • [3] Serum Midkine as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma
    Hung, Yi-Ju
    Lin, Zoe H. Y.
    Cheng, Tsun-I
    Liang, Chung-Ting
    Kuo, Tse-Ming
    Kao, Kuo-Jang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (04) : 594 - 603
  • [4] Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma
    Ni, Xiao-Chun
    Yi, Yong
    Fu, Yi-Peng
    He, Hong-Wei
    Cai, Xiao-Yan
    Wang, Jia-Xing
    Zhou, Jian
    Fan, Jia
    Qiu, Shuang-Jian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10713 - 10718
  • [5] Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
    Ozaki, Kazuaki
    Toshikuni, Nobuyuki
    George, Joseph
    Minato, Takahiro
    Matsue, Yasuhiro
    Arisawa, Tomiyasu
    Tsutsumi, Mikihiro
    JOURNAL OF CANCER, 2014, 5 (03): : 221 - 230
  • [6] SERUM ANGIOPOIETIN 2 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN HEPATOCELLULAR CARCINOMA
    Chiba, Tetsuhiro
    Ao, Junjie
    Kanzaki, Hiroaki
    Ma, Yaojia
    Iwanaga, Terunao
    Sakuma, Takahumi
    Kan, Motoyasu
    Fujita, Naoto
    Koroki, Keisuke
    Kanayama, Ken Go
    Kobayashi, Kazuhumi
    Nakamura, Masato
    Kanogawa, Naoya
    Kiyono, Soichiro
    Kondo, Takayuki
    Saito, Tomoko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Nakagawa, Ryo
    Muroyama, Ryosuke
    Kato, Naoya
    HEPATOLOGY, 2020, 72 : 685A - 686A
  • [7] A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma
    Fan, Sha-Sha
    Liao, Chu-Shu
    Cao, You-De
    Xiao, Pei-Ling
    Deng, Tan
    Luo, Rong-Cheng
    Duan, Hua-Xin
    ONCOLOGY LETTERS, 2017, 13 (06) : 4208 - 4214
  • [8] THE VALUE OF PRETREATMENT SERUM PSEUDOCHOLINESTERASE LEVEL AS NOVEL PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
    Poetsch, N.
    Sturdza, A.
    Aust, S.
    Polterauer, S.
    Grimm, C.
    Schwameis, R.
    Koelbl, H.
    Reinthaller, A.
    Seebacher, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 851 - 851
  • [9] THE VALUE OF PRETREATMENT SERUM PSEUDOCHOLINESTERASE LEVEL AS NOVEL PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
    Poetsch, N.
    Sturdza, A.
    Aust, S.
    Polterauer, S.
    Grimm, C.
    Schwameis, R.
    Koelbl, H.
    Reinthaller, A.
    Seebacher, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 386 - 386
  • [10] Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
    Ao, Junjie
    Chiba, Tetsuhiro
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Shibata, Shuhei
    Kurosugi, Akane
    Iwanaga, Terunao
    Kan, Motoyasu
    Sakuma, Takafumi
    Qiang, Na
    Ma, Yaojia
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Kanogawa, Naoya
    Saito, Tomoko
    Nakagawa, Ryo
    Kondo, Takayuki
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Kato, Jun
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF CANCER, 2021, 12 (09): : 2694 - 2701
12345